MARKET

AVCTF

AVCTF

Avacta Group
OTCPK
0.943
NaN%
Closed 09:30 03/27 EDT
OPEN
--
PREV CLOSE
0.943
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.110
52 WEEK LOW
0.642
MARKET CAP
415.44M
P/E (TTM)
-4.3570
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AVCTF last week (0316-0320)?
Weekly Report · 6d ago
Avacta Announces Preclinical and Translational Presentations of pre|CISION® Platform Candidates at the 2026 AACR Annual Conference
Barchart · 03/17 02:00
Weekly Report: what happened at AVCTF last week (0309-0313)?
Weekly Report · 03/16 09:42
Weekly Report: what happened at AVCTF last week (0302-0306)?
Weekly Report · 03/09 09:44
Weekly Report: what happened at AVCTF last week (0223-0227)?
Weekly Report · 03/02 09:43
Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis
Barchart · 02/24 01:00
Weekly Report: what happened at AVCTF last week (0216-0220)?
Weekly Report · 02/23 09:42
Weekly Report: what happened at AVCTF last week (0209-0213)?
Weekly Report · 02/16 09:42
More
About AVCTF
Avacta Group plc is a United Kingdom-based life sciences company developing peptide drug conjugates (PDC) targeting anti-tumor payloads directly to the tumor. The Company is focused on the development of its proprietary preCISION technology platform. The preCISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preCISION platform harnesses this tumor-specific protease to cleave preCISION peptide drug conjugates and preCISION antibody/Affimer drug conjugates in the tumor microenvironment, thus releasing active payload in the tumor and reducing systemic exposure and toxicity. Its lead program, AVA6000, is a clinical-stage asset which is a preCISION-enabled form of doxorubicin. AVA6103, the Company’s second program, is a preCISION-enabled PDC comprised of the preCISION peptide linked to exatecan, the most potent topoisomerase I (topo I) inhibitor in clinical development.

Webull offers Avacta Group Plc stock information, including OTCPK: AVCTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVCTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVCTF stock methods without spending real money on the virtual paper trading platform.